STOCK TITAN

Inhibikase Therapeutics, Inc. (IKT) Revenue by Year

IKT

Inhibikase Therapeutics, Inc. does not report revenue for fiscal year 2025, so the figure is not reported on this page. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Inhibikase Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue N/A
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

IKT Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
RevenueN/A$0-100.0%$261K+111.0%$123K-96.0%$3.1M+343.9%$698K

IKT Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$0$0N/A$0$0$0N/A$0-100.0%$0-100.0%$0-100.0%$1-100.0%$80K+991.3%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Inhibikase Therapeutics, Inc. financials

Frequently Asked Questions

What was Inhibikase Therapeutics, Inc.'s revenue in fiscal year 2025?

Inhibikase Therapeutics, Inc. does not report revenue for fiscal year 2025, so the figure is not reported on this page.

What was Inhibikase Therapeutics, Inc.'s revenue in the most recent quarter?

Inhibikase Therapeutics, Inc. (IKT) reported $0 in revenue in Q2 2026.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Inhibikase Therapeutics, Inc. (IKT) reported on that line in every period on record.